Valeant Pharmaceuticals | search
Click here to view Valeant Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Valeant Will Become Bausch Health Companies Inc.Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
- Valeant Will Become Bausch Health Companies Inc. - PR NewswireWe develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
- Bausch Health - WikipediaBausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health ...
- Valeant Pharmaceuticals International, Inc. (VRX) - Yahoo FinanceFind the latest Valeant Pharmaceuticals International, Inc. (VRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
- SEC.gov | Pharmaceutical Company and Former Executives Charged With ...Washington D.C., July 31, 2020 —. The Securities and Exchange Commission today announced that Bausch Health, formerly Quebec, Canada-based Valeant Pharmaceuticals, agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC filings and earnings presentations.
More
